Anuh Pharma last traded at ₹81.10 (2026-10-13). Over the past month the stock moved -11.8%, three months the stock moved +5.9%, year the stock moved -7.6%. Its closing range over 52 weeks is ₹70.21 – ₹108.00, with the latest close 24.9% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]
Part of SK Group of companies:[1] The company is a bulk drug manufacturing company, and is part of the Rs. 8.5 billion SK Group. SK Group employs approximately 2,200 people across businesses including pharmaceutical formulations manufacturing, Trading, Distribution and Logistics (primarily for large MNC brands).
In the latest quarter (Jun 2026), Anuh Pharma reported sales of ₹194.00 crore (+4.3%) and net profit of ₹11.00 crore (+37.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 194.00 | 16.00 | 8.00 | 11.00 | 1.14 |
| Mar 2026 | 202.00 | 20.00 | 10.00 | 12.00 | 1.17 |
| Dec 2025 | 197.00 | 19.00 | 10.00 | 13.00 | 1.34 |
| Sep 2025 | 186.00 | 12.00 | 6.00 | 8.00 | 0.76 |
| Jun 2025 | 186.00 | 10.00 | 6.00 | 8.00 | 0.83 |
| Mar 2025 | 198.00 | 19.00 | 9.00 | 12.00 | 1.24 |
| Dec 2024 | 160.00 | 15.00 | 9.00 | 10.00 | 1.03 |
| Sep 2024 | 166.00 | 17.00 | 10.00 | 15.00 | 1.50 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.7% | -7.0% | +20.7% | +34.8% | +12.0% | +23.1% | +2.0% | +4.3% |
| Operating profit growth | -5.6% | -37.5% | +0.0% | -9.1% | -29.4% | +26.7% | +5.3% | +60.0% |
| Net profit growth | +7.1% | -47.4% | -20.0% | -20.0% | -46.7% | +30.0% | +0.0% | +37.5% |
| EPS growth | +8.7% | -46.1% | -19.0% | -12.6% | -49.3% | +30.1% | -5.6% | +37.3% |
| OPM % | 10.0% | 9.0% | 9.0% | 6.0% | 6.0% | 10.0% | 10.0% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Anuh Pharma reported sales of ₹772.00 crore (+16.6%) and net profit of ₹41.00 crore (-12.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 772.00 | 62.00 | 8.00 | 41.00 | 4.10 |
| Mar 2025 | 662.00 | 61.00 | 9.00 | 47.00 | 4.73 |
| Mar 2024 | 647.00 | 76.00 | 12.00 | 60.00 | 5.99 |
| Mar 2023 | 527.00 | 52.00 | 10.00 | 36.00 | 3.61 |
| Mar 2022 | 487.00 | 47.00 | 10.00 | 31.00 | 3.05 |
| Mar 2021 | 432.00 | 45.00 | 10.00 | 28.00 | 2.84 |
| Mar 2020 | 307.00 | 23.00 | 8.00 | 14.00 | 1.43 |
| Mar 2019 | 321.00 | 30.00 | 9.00 | 23.00 | 2.33 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +34.9% | -4.4% | +40.7% | +12.7% | +8.2% | +22.8% | +2.3% | +16.6% |
| Operating profit growth | +66.7% | -23.3% | +95.7% | +4.4% | +10.6% | +46.2% | -19.7% | +1.6% |
| Net profit growth | +35.3% | -39.1% | +100.0% | +10.7% | +16.1% | +66.7% | -21.7% | -12.8% |
| EPS growth | +41.2% | -38.6% | +98.6% | +7.4% | +18.4% | +65.9% | -21.0% | -13.3% |
| OPM % | 9.0% | 8.0% | 10.0% | 10.0% | 10.0% | 12.0% | 9.0% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Anuh Pharma.
Get Free AI Stock Analysis FREE →No recent news available for Anuh Pharma.
Anuh Pharma shares were last quoted at ₹81.10 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Anuh Pharma has a price-to-earnings (P/E) ratio of 20.48 and a price-to-book (P/B) ratio of 2.49. The industry P/E is 53.33.
The 52-week high of Anuh Pharma is ₹99.50 and the 52-week low is ₹66.72.
The market capitalisation of Anuh Pharma is about ₹905.02 crore.
In the latest quarter (Jun 2026), Anuh Pharma reported sales of ₹194.00 crore (+4.3%) and net profit of ₹11.00 crore (+37.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Anuh Pharma has a 3-year ROE of 14.00%, 3-year profit growth of 3.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 71.79% of Anuh Pharma.
Anuh Pharma belongs to the Pharmaceuticals & Drugs sector.